TERRY CAMPBELL: Open Payments
NPI 1740949692 · TAYLORSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 104 payments from 12 companies in 2025. Trend: 2023 $1,263 · 2024 $1,179 · 2025 $2,300
Food & beverage: $2,200Education: $100
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $417 |
| Otsuka America Pharmaceutical, Inc. | 11 | $356 |
| Alkermes, Inc. | 23 | $322 |
| Teva Pharmaceuticals USA, Inc. | 14 | $319 |
| Neurocrine BioSciences, Inc. | 14 | $310 |
| ABBVIE INC. | 11 | $239 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| Indivior Inc. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: FANAPT, INGREZZA, ARISTADA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI.
Industry payments across NC — which companies pay providers there.
